Nataliya G. Yeremenko

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Dual impact of interleukin-17 A blockade on inflammatory and stromal pathways in peripheral spondyloarthritis.

Dual impact of interleukin-17 A blockade on inflammatory and stromal pathways in peripheral spondyloarthritis.

Journal: Arthritis research & therapy

Published: March 16, 2025

IgA-Producing B Cells Exert Regulatory Function through Granzyme B in Kidney Allograft Tolerance.

IgA-Producing B Cells Exert Regulatory Function through Granzyme B in Kidney Allograft Tolerance.

Journal: Kidney360

Published: January 27, 2025

IgA-Producing B Cells Exert Regulatory Function Through Granzyme B in Kidney Allograft Tolerance.

IgA-Producing B Cells Exert Regulatory Function Through Granzyme B in Kidney Allograft Tolerance.

Journal: Kidney360

Published: January 27, 2025

Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.

Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.

Journal: Biomolecules

Published: November 13, 2023

Chronic Release of Tailless Phage Particles from Lactococcus lactis.

Chronic Release of Tailless Phage Particles from Lactococcus lactis.

Journal: Applied and environmental microbiology

Published: October 27, 2021

Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis.

Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis.

Journal: Current opinion in rheumatology

Published: May 18, 2021

Transcriptional regulator BOB.1: Molecular mechanisms and emerging role in chronic inflammation and autoimmunity.

Transcriptional regulator BOB.1: Molecular mechanisms and emerging role in chronic inflammation and autoimmunity.

Journal: Autoimmunity reviews

Published: January 20, 2021

IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.

IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.

Journal: Frontiers in immunology

Published: September 29, 2020

Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis.

Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis.

Journal: The Journal of experimental medicine

Published: February 17, 2020

Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis.

Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis.

Journal: The Journal of rheumatology

Published: December 10, 2019

Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.

Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.

Journal: Journal of autoimmunity

Published: November 22, 2019

Correction: HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort.

Correction: HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort.

Journal: Genes and immunity

Published: May 10, 2019

Showing 1-12 of 43

Last Updated: 09/26/2026